The Kabuki Syndrome in 18F-FDG-PET/CT
A 36-year-old man with a history of relapsing infections, cytopenia, and lymphadenopathy was referred for 18 F-FDG-PET/CT to investigate suspected lymphoma. His medical history revealed cardiac surgery during childhood for unknown reasons. Laboratory tests revealed hypogammaglobinemia and elevated soluble IL-2-receptor levels as a sign of inflammation. PET/CT demonstrated generalized lymphadenopathy, splenic and muscle lesions, being more consistent with sarcoidosis than lymphoma. Subsequent excision biopsy of a lymph node and bone marrow biopsy were negative for malignancy. Treatment with high-dose abatacept resulted in complete remission. Genetic testing identified a pathogenic de-novo variant in the KMT2D gene, leading to a diagnosis of Kabuki syndrome.
Authors
- Magdeldin Elgizouli (ORCID: https://orcid.org/0000-0001-7424-4938)
- Martin William Huellner (ORCID: https://orcid.org/0000-0002-4849-3292)
- Jakob Nilsson (ORCID: https://orcid.org/0000-0001-5091-8133)
- Fatemeh Dana
Institutions
- University of Zurich (CH)
- University Hospital of Zurich (CH)
Publication Details
- Journal
- Clinical Nuclear Medicine
- Published
- 2025-08-12
- DOI
- https://doi.org/10.1097/rlu.0000000000005960
- Primary Topic
- Genomics and Rare Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00